These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 26292300

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Detection of quinolone-resistant Neisseria gonorrhoeae in urogenital specimens with the use of real-time polymerase chain reaction.
    Siedner MJ, Pandori M, Leon SR, Barry PM, Espinosa BJ, Hall ER, Coates TJ, Klausner JD, NIMH Collaborative HIV/STD Prevention Trial Group.
    Int J STD AIDS; 2008 Jan; 19(1):69-71. PubMed ID: 18275657
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
    Abe H, Nishimura T, Norose Y, Aoto T, Ohzuka H, Ohkuni H.
    J Infect Chemother; 2003 Dec; 9(4):310-3. PubMed ID: 14691651
    [Abstract] [Full Text] [Related]

  • 46. Analytical specificity and sensitivity of the novel dual-target GeneProof Neisseria gonorrhoeae PCR kit for detection of N. gonorrhoeae.
    Golparian D, Hellmark B, Unemo M.
    APMIS; 2015 Nov; 123(11):955-8. PubMed ID: 26332192
    [Abstract] [Full Text] [Related]

  • 47. Development of Cas13a-based assays for Neisseria gonorrhoeae detection and gyrase A determination.
    Allan-Blitz L-T, Shah P, Adams G, Branda JA, Klausner JD, Goldstein R, Sabeti PC, Lemieux JE.
    mSphere; 2023 Oct 24; 8(5):e0041623. PubMed ID: 37732792
    [Abstract] [Full Text] [Related]

  • 48. Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.
    Allan-Blitz LT, Ellis OL, Wee R, Truong A, Ebeyan SM, Tan LY, Mokany E, Flynn R, Klausner JD.
    J Antimicrob Chemother; 2019 Oct 01; 74(10):2913-2915. PubMed ID: 31340021
    [Abstract] [Full Text] [Related]

  • 49. Nalidixic acid-susceptible, ciprofloxacin-resistant Neisseria gonorrhoeae strain in the UK.
    Ragunathan PL, Ison C, Livermore DM.
    J Antimicrob Chemother; 2005 Aug 01; 56(2):437. PubMed ID: 15967768
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Evaluation of six nucleic acid amplification tests used for diagnosis of Neisseria gonorrhoeae in Russia compared with an international strictly validated real-time porA pseudogene polymerase chain reaction.
    Shipitsyna E, Zolotoverkhaya E, Hjelmevoll SO, Maximova A, Savicheva A, Sokolovsky E, Skogen V, Domeika M, Unemo M.
    J Eur Acad Dermatol Venereol; 2009 Nov 01; 23(11):1246-53. PubMed ID: 19453773
    [Abstract] [Full Text] [Related]

  • 54. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X, Lind I.
    Antimicrob Agents Chemother; 2001 Jan 01; 45(1):117-23. PubMed ID: 11120953
    [Abstract] [Full Text] [Related]

  • 55. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
    Tanaka M, Nakayama H, Huruya K, Konomi I, Irie S, Kanayama A, Saika T, Kobayashi I.
    Int J Antimicrob Agents; 2006 Jan 01; 27(1):20-6. PubMed ID: 16318912
    [Abstract] [Full Text] [Related]

  • 56. Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
    Sato K.
    J Infect Chemother; 2003 Dec 01; 9(4):361. PubMed ID: 14691662
    [No Abstract] [Full Text] [Related]

  • 57. Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
    Allan-Blitz LT, Humphries RM, Hemarajata P, Bhatti A, Pandori MW, Siedner MJ, Klausner JD.
    Clin Infect Dis; 2017 May 01; 64(9):1268-1270. PubMed ID: 28034887
    [Abstract] [Full Text] [Related]

  • 58. Ciprofloxacin May be Efficacious in Treating Wild-Type Gyrase A Genotype Neisseria gonorrhoeae Infections.
    Allan-Blitz LT, Hemarajata P, Humphries RM, Kimble M, Elias S, Klausner JD.
    Sex Transm Dis; 2018 Apr 01; 45(4):e18. PubMed ID: 29465685
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.